PLoS ONE · 2011 · 149 citations · 30 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsImmunology Of Infectious DiseasesInnate ImmunityAntiviral ImmunityInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysToll-like ReceptorsViral HepatitisAntiviral Innate SignalingChronic Viral HepatitisDendritic Cell Antiviral ResponsesInhibition Of Interferon ResponsesInterference With Interferon SignalingInterferon Response To Viral InfectionPlasmacytoid Dendritic Cell Interferon ResponsesToll-like Receptor Signaling
Plasmacytoid dendritic cells (pDCs) play a key role in detecting pathogens by producing large amounts of type I interferon (IFN) by sensing the presence of viral infections through the Toll-Like Receptor (TLR) pathway. TLR9 is a sensor of viral and bacterial DNA motifs and activates the IRF7 transcription factor which leads to type I IFN secretion by pDCs. However, during chronic hepatitis B virus (HBV) infection, pDCs display an impaired ability to secrete IFN-α following ex vivo stimulation with TLR9 ligands. Here we highlight several strategies used by HBV to block IFN-α production through a specific impairment of the TLR9 signaling. Our results show that HBV particle internalisation could inhibit TLR9- but not TLR7-mediated secretion of IFN-α by pDCs. We observed that HBV down-regulated TLR9 transcriptional activity in pDCs and B cells in which TLR9 mRNA and protein levels were reduced. HBV can interfere with TLR9 activity by blocking the MyD88-IRAK4 axis and Sendai virus targeting IRF7 to block IFN-α production. Neutralising CpG motif sequences were identified within HBV DNA genome of genotypes A to H which displayed a suppressive effect on TLR9-immune activation. Moreover, TLR9 mRNA and protein were downregulated in PBMCs from patients with HBV-associated chronic hepatitis and hepatocellular carcinoma. Thus HBV has developed several escape mechanisms to avoid TLR9 activation in both pDCs and B lymphocytes, which may in turn contribute to the establishment and/or persistence of chronic infection.
30
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sonia Sharma, Benjamin R. tenOever, Nathalie Grandvaux et al. · Science · 2003 · 1.7K citations
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Hiroki Kato, Shintaro Sato, Mitsutoshi Yoneyama et al. · Immunity · 2005 · 1.3K citations · Full text